2022 annual financial data
Spruce Biosciences 2022 Operating margin
Spruce Biosciences 2022 operating margin with verified reported values.
Direct answer
Operating margin was -2,407.48%.
Operating income was -47,283,000 USD and net income was -46,180,000 USD.
Operating cash flow was -41,683,000 USD.
Get free Spruce Biosciences email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 1,964,000 USD
- Operating income
- -47,283,000 USD
- Net income
- -46,180,000 USD
- Operating cash flow
- -41,683,000 USD